MM-MSCs present reduced inhibitory efficiency towards T lymphocyte proliferation and reduced production of TGF-β, which could lead both to escape immune control and to reduced apoptosis of MM cells [152]. This evidence concerns the gene TGFB1 and Miyoshi myopathy.